Syrs stocktwits
Researching Syros Pharmaceuticals (NASDAQ:SYRS) stock? View SYRS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC What are top-rated research analysts are saying about Syros Pharmaceuticals (NASDAQ:SYRS)? View SYRS's most recent analyst ratings, analyst estimates Nov 12, 2019 Syros Pharmaceuticals (SYRS) Receives a Buy from Cowen & Co. By Austin Angelo. Cowen Share on StockTwits · NASDAQ:SYRS, Phil CDE, Long, 7.20, 7.14 to 7.26, 7.39 to 7.52, 7.07 to 6.99, 593,797, 09:38 AM, 7.20. SYRS, Long, 7.44, 7.37 to 7.51, 7.66 to 7.81, 7.29 to 7.20, 308,608, 09:33 AM Popular Now StockTwits logo · SAVA AAL MIK PHAS ITRM RAD GNL DBVT QNST SE BLK PRGO SPOT FIXX FLT BE SYRS GASX SPXS TNA RES VRNA PDD
Technical stock forecast for SYRS: Syros Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of
This week both an 80 page report on AIPT and an interview with CEO in which he says they have pending deals in works for Helomics, quite the setup here on Jun 29, 2016 Syros Pharmaceuticals ($SYRS) aims to use small molecules to control the activation and repression of genes in cancer and immune-mediated Dec 19, 2019 Share on StockTwits. Join our SYRS shares opened higher today at $4.88 (+$0.26, +5.63%) compared to yesterday's $4.62 closing price. SGEN ARNA MBIO ASLN AMAG BLPH ORTX SWTX SYRS ZLAB PLX PRVB · Provention's Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show. The latest Tweets from NickTrades (@Nicktrades20). Equities Trader Going Long and Short. Live streaming my trading every morning on YouTube!Join our free
Syros Pharmaceuticals Inc. Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It i primarily involved in the segments of the pharmaceutical, biotechnology and other related markets that address gene control and cancer.
Ideanomics' MEG Group reports up to $24M in logistical vehicle orders. Ideanomics (IDEX +3.3%) is up after its MEG segment announces an initial order for 1,200 TD SELL detected for ARW (Arrow Electronics, I) at the close price of 71.27 with a support level at 66.99 and a resistance at 71.27, providing an opportunity for a 6
CDE, Long, 7.20, 7.14 to 7.26, 7.39 to 7.52, 7.07 to 6.99, 593,797, 09:38 AM, 7.20. SYRS, Long, 7.44, 7.37 to 7.51, 7.66 to 7.81, 7.29 to 7.20, 308,608, 09:33 AM
Syros Pharmaceuticals board appointment a 'major win,' says Roth Capital - $SYRS - thefly.com/landingPageNews. 1. theflynews12/20/19, 09:30 AM.
11/11/2017 · Find the latest RESHAPE LIFESCIENCES INC (RSLS) stock quote, history, news and other vital information to help you with your stock trading and investing.
11/11/2017 · Find the latest RESHAPE LIFESCIENCES INC (RSLS) stock quote, history, news and other vital information to help you with your stock trading and investing. 11/17/2014 · Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 100,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company. PTI | Complete Proteostasis Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long and Short Trading Ideas using Insider 12/19/2019 · Neovasc Inc. Common Shares (NVCN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
This week both an 80 page report on AIPT and an interview with CEO in which he says they have pending deals in works for Helomics, quite the setup here on